Application | Comment | Organism |
---|---|---|
medicine | enzyme deficiency is characterized by malonic aciduria, developmental delay, seizure disorder, and mental retardation | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
from heart, overexpression of full-length and N-terminal truncated hMCD in Escherichia coli BL21 (DE3), sequencing | Homo sapiens |
Crystallization (Comment) | Organism |
---|---|
- |
Homo sapiens |
General Stability | Organism |
---|---|
the N-terminal region of hMCD plays a role in the folding process and conformation stability of enzyme | Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.33 | 0.52 | malonyl-CoA | full-length and N-terminal truncated apo-hMCD | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytoplasm | - |
Homo sapiens | 5737 | - |
additional information | full-length MCD contains a putative, N-terminal 39 amino acid mitochondria targeting sequence and a peroxisomal tageting sequence | Homo sapiens | - |
- |
soluble | - |
Homo sapiens | - |
- |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
additional information | no requirement of divalent metal ions | Homo sapiens |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
50000 | - |
x * 50000, about, wild-type apo-hMCD, SDS-PAGE | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
Malonyl-CoA | Homo sapiens | plays a critical role in fatty-acid metabolism, precursor hMCD plays a role in the regulation of the cytosolic malonyl-CoA level in cells | Acetyl-CoA + CO2 | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
proteolytic modification | full-length MCD contains a putative, N-terminal 39 amino acid mitochondria targeting sequence and a peroxisomal tageting sequence | Homo sapiens |
Purification (Comment) | Organism |
---|---|
recombinant full-length and N-terminal truncated apoenzymes | Homo sapiens |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
- |
Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Malonyl-CoA | - |
Homo sapiens | Acetyl-CoA + CO2 | - |
? | |
Malonyl-CoA | plays a critical role in fatty-acid metabolism, precursor hMCD plays a role in the regulation of the cytosolic malonyl-CoA level in cells | Homo sapiens | Acetyl-CoA + CO2 | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 50000, about, wild-type apo-hMCD, SDS-PAGE | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
hMCD | - |
Homo sapiens |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
13 | 28 | malonyl-CoA | full-length and N-terminal truncated apo-hMCD | Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
additional information | no cofactor requirement | Homo sapiens |
Organism | Comment | pI Value Maximum | pI Value |
---|---|---|---|
Homo sapiens | theoretical pI, N-terminal truncated apo-hMCD | - |
8 |
Homo sapiens | theoretical pI, wild-type hMCD | - |
9.1 |